These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 18207486)

  • 1. The magnocellular pathway and schizophrenia.
    Kéri S
    Vision Res; 2008 Apr; 48(9):1181-2; author reply 1183-5. PubMed ID: 18207486
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast sensitivity and magnocellular functioning in schizophrenia.
    Skottun BC; Skoyles JR
    Vision Res; 2007 Oct; 47(23):2923-33. PubMed ID: 17825350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A few remarks on assessing magnocellular sensitivity in Schizophrenic patients.
    Skottun BC; Skoyles J
    Brain; 2007 Nov; 130(Pt 11):e83; author reply e84. PubMed ID: 17627964
    [No Abstract]   [Full Text] [Related]  

  • 4. Low spatial frequency contrast sensitivity deficits in migraine are not visual pathway selective.
    McKendrick AM; Sampson GP
    Cephalalgia; 2009 May; 29(5):539-49. PubMed ID: 19250285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are masking abnormalities in schizophrenia limited to backward masking?
    Skottun BC; Skoyles JR
    Int J Neurosci; 2009; 119(1):88-104. PubMed ID: 19116834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslexia, direction selectivity and magnocellular sensitivity.
    Skottun BC; Skoyles J
    Vision Res; 2007 Jun; 47(14):1974-5; author reply 1976-7. PubMed ID: 17316741
    [No Abstract]   [Full Text] [Related]  

  • 7. Grasping behavior in schizophrenia suggests selective impairment in the dorsal visual pathway.
    King JP; Christensen BK; Westwood DA
    J Abnorm Psychol; 2008 Nov; 117(4):799-811. PubMed ID: 19025227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Greetings from the Editor].
    Degrell I
    Psychiatr Hung; 2008; 23(3):149. PubMed ID: 18956621
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of impaired facial affect recognition with basic facial and visual processing deficits in schizophrenia.
    Norton D; McBain R; Holt DJ; Ongur D; Chen Y
    Biol Psychiatry; 2009 Jun; 65(12):1094-8. PubMed ID: 19268917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motion integration deficits are independent of magnocellular impairment in Parkinson's disease.
    Castelo-Branco M; Mendes M; Silva F; Massano J; Januário G; Januário C; Freire A
    Neuropsychologia; 2009 Jan; 47(2):314-20. PubMed ID: 18822307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foveal contrast processing of increment and decrement targets is equivalently reduced in glaucoma.
    Sampson GP; Badcock DR; Walland MJ; McKendrick AM
    Br J Ophthalmol; 2008 Sep; 92(9):1287-92. PubMed ID: 18614574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplitude of the transient visual evoked potential (tVEP) as a function of achromatic and chromatic contrast: contribution of different visual pathways.
    Souza GS; Gomes BD; Lacerda EM; Saito CA; da Silva Filho M; Silveira LC
    Vis Neurosci; 2008; 25(3):317-25. PubMed ID: 18321403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the functional integrity of the dorsal visual pathway in autism and dyslexia.
    Pellicano E; Gibson LY
    Neuropsychologia; 2008 Aug; 46(10):2593-6. PubMed ID: 18501932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The advantage in being magnocellular: a few more remarks on attention and the magnocellular system.
    Laycock R; Crewther DP; Crewther SG
    Neurosci Biobehav Rev; 2008 Oct; 32(8):1409-15. PubMed ID: 18514901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychophysical analysis of contrast processing segregated into magnocellular and parvocellular systems in asymptomatic carriers of 11778 Leber's hereditary optic neuropathy.
    Gualtieri M; Bandeira M; Hamer RD; Costa MF; Oliveira AG; Moura AL; Sadun F; De Negri AM; Berezovsky A; Salomão SR; Carelli V; Sadun AA; Ventura DF
    Vis Neurosci; 2008; 25(3):469-74. PubMed ID: 18598420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial summation properties for magnocellular and parvocellular pathways in glaucoma.
    Battista J; Badcock DR; McKendrick AM
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1221-6. PubMed ID: 18936145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual pathway deficit in female fragile X premutation carriers: a potential endophenotype.
    Kéri S; Benedek G
    Brain Cogn; 2009 Mar; 69(2):291-5. PubMed ID: 18789568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parvocellular and magnocellular contributions to the initial generators of the visual evoked potential: high-density electrical mapping of the "C1" component.
    Foxe JJ; Strugstad EC; Sehatpour P; Molholm S; Pasieka W; Schroeder CE; McCourt ME
    Brain Topogr; 2008 Sep; 21(1):11-21. PubMed ID: 18784997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: a neuropsychological comparison.
    Tumkaya S; Karadag F; Oguzhanoglu NK; Tekkanat C; Varma G; Ozdel O; Ateşçi F
    Psychiatry Res; 2009 Jan; 165(1-2):38-46. PubMed ID: 18995914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metacontrast, target recovery, and the magno- and parvocellular systems: a reply to the perspective.
    Oğmen H; Purushothaman G; Breitmeyer BG
    Vis Neurosci; 2008; 25(4):611-6. PubMed ID: 18764961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.